Related Experiment Video
Updated: Oct 25, 2025
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
24.6K
Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview
1Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA.
Diabetes & Metabolic Syndrome
|August 9, 2021
Summary
This review explores how pharmacogenomics impacts type 2 diabetes mellitus (T2DM) medication effectiveness. Understanding these genetic variations can lead to personalized T2DM therapies for better glucose control.
Area of Science:
- Pharmacogenomics
- Endocrinology
- Metabolic Diseases
Background:
- Type 2 diabetes mellitus (T2DM) is a global health concern with rising incidence.
- Effective T2DM management aims to control blood glucose and prevent disease progression.
Purpose of the Study:
- To review the influence of pharmacogenomics on major T2DM medications.
- To explore personalized therapeutic strategies for T2DM.
Main Methods:
- Literature review of pharmacogenomic studies related to T2DM treatments.
- Analysis of genetic variations affecting drug response.
Main Results:
- Significant patient-to-patient variability in T2DM medication response exists.
- Pharmacogenomic differences underlie variations in efficacy and side effects.
Conclusions:
- Personalized medicine approaches are crucial for optimizing T2DM treatment.
- Tailoring T2DM therapies based on genetic profiles can improve patient outcomes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
3.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
01:15Diabetes: Management and Pharmacotherapy
592
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
592
01:22Diabetes Mellitus: Overview and Type I Subtype
4.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.0K
01:36Carbohydrate Metabolism
12.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.7K
01:20Pathophysiology of Diabetes
2.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
01:11Genome-wide Association Studies-GWAS
14.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.8K